Queensland researchers have made a big leap forward in their quest to eradicate the billions of cane toads wreaking havoc on our native wildlife and habitats.

Environmentally friendly cane toad traps – developed by a team of researchers from The University of Queensland and The University of Sydney – are one step closer to production, following an agreement between UQ and US-based pest control company, SpringStar Inc.

Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

Taking medicine in the future could be as simple as eating a sunflower seed or drinking a cup of tea made from herbs grown in your own garden.

An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.

Join leading clinical pain scientist, Professor Lorimer Moseley, and IMB researchers as they discuss how the challenging and personal nature of pain is inspiring a new generation of patient-focused treatments for one of the most poorly understood and undertreated conditions in modern medicine.

UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).

Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.

IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at UQ's St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.

You are invited to join us for a free half-day Membrane Trafficking and Dynamics Symposium on 18 April 2016 at IMB.